Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01977651 |
Title | A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide |
Acronym | UPWARD |
Recruitment | Completed |
Gender | male |
Phase | FDA approved |
Variant Requirements | No |
Sponsors | Astellas Pharma Global Development, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | SWE | NZL | ITA | ISR | HUN | GBR | FRA | FIN | ESP | DEU | CZE | CAN | BEL | AUS | ARG |